邦訊技術(300312.SZ)收到北京興華的告知函 其不再作為公司2019年度審計機構
格隆匯1月10日丨邦訊技術(300312.SZ)公佈,公司於2019年5月24日召開2018年度股東大會,審議通過了《關於續聘2019年度審計機構的議案》,同意續聘北京興華會計師事務所(特殊普通合夥)(“北京興華”)為公司2019年度審計機構。
公司於近日收到北京興華的告知函,北京興華不再作為公司2019年度審計機構,為公司提供審計服務。為保證公司2019年度審計工作正常開展,經綜合考慮,公司擬聘請立信中聯會計師事務所(特殊普通合夥)為公司2019年度財務審計機構。根據相關規定,公司聘任審計機構需召開董事會及股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.